Loading…
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
33pct
2d open
vs 6,526 other HR bills in the 114th — cohort avg 56d
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 This bill amends the Public Health Service Act to require the Department of Health and Human Services to make grants to states to: (1) collect data on the prevalence and distribution of sickle cell disease, (2) conduct sickle cell disease public health initiatives to improve access to care and health outcomes, and (3) identify and evaluate strategies for prevention and treatment of sickle cell disease complications. The demonstration program to improve the prevention and treatment of sickle cell disease is revised, extended indefinitely, and moved from the American Jobs Creation Act of 2004 to the Public Health Service Act.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (6)
2016 · fourth_quarter · Health Issues
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6, H.R. 34) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
2016 · fourth_quarter · Health Issues
H.R. 3762, Restoring Americans Healthcare Freedom Reconciliation Act H.R. 592/S. 314, Pharmacy and Medically Underserved Areas Enhancement Act H.R. 954, CO-OP Consumer Protection Act of 2016 H.R. 1190/S. 141, The Protecting Seniors Access to Medicare Act of 2015 H.R. 1192, National Clinical Care Commission Act H.R. 1270, Restoring Access to Medication and Improving Health Savings Act H.R. 1427, Medicare CGM Access Act H.R. 1686/S. 3082, Preventing Diabetes in Medicare Act H.R. 1707, Access to Frontline Health Care Act of 2015 H.R. 1726, Access to Quality Diabetes Education Act H.R. 1807, Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 H.R. 2102, Medicare Diabetes Prevention Act H.R. 2124/S. 1148, Resident Physician Shortage Act H.R. 2603/S. 1475, Saving Lives, Saving Costs Act H.R. 2646, Helping Families in Mental Crisis Act H.R. 2713/S. 3245, Title VIII Nursing Workforce Reauthorization Act of 2016 H.R. 3081/S. 1778, Telemedicine for Medicare Act H.R. 3119/S. 2748, Palliative Care and Hospice Education and Training Act H.R. 3660/S. 3126,Preventive Health Savings Act H.R. 3952/S. 2248, Congenital Heart Future Reauthorization Act of 2015 H.R. 4212/S. 704, Community Based Independence for Seniors Act of 2015 H.R. 4442/S. 2484, CONNECT for Health Act H.R. 4732/S. 2671, Advancing Medical Resident Training in Community Hospitals Act H.R. 4774, Training Tomorrows Doctors Today Act H.R. 4909/S. 2943, National Defense Authorization Act H.R. 5273, Helping Hospitals Improve Patient Care Act H.R. 5414, FDA Cross-Center Collaboration Act H.R. 5447/S. 3060, The Small Business Health Care Relief Act H.R. 5652,Access to Better Care Act H.R. 5681/S. 3137, Alzheimers Beneficiary and Caregiver Support Act H.R. 5713, Sustaining Healthcare Integrity and Fair Treatment Act of 2016 H.R.5926 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 H.R. 6043/S. 3335, The Fair Accountability and Innovative Research Drug Pricing Act of 2016 H.R. 6109/S. 3371, Medicare Affordability and Enrollment Act S. 524, Comprehensive Addiction and Recovery Act S. 586, National Diabetes Clinical Care Commission Act S. 603, Jobs and Premium Protection Act S. 776,Medication Therapy Management Empowerment Act S. 1077,Advancing Breakthrough Medical Devices for Patients Act S. 1101,Medical Electronic Data Technology Enhancement for Consumers Health (MEDTECH) Act S. 1622,FDA Device Accountability Act S. 2511,Improving Health Information Technology Act S. 2680,Mental Health Reform Act of 2016 S. 2864,Reducing Existing Costs Associated with Pharmaceuticals for Seniors Act of 2016 S. 3326,State Flexibility to Provide Affordable Health Options Act S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2016 Pub. L. 111-5, The American Recovery and Reinvestment Act of 2009 (Health Information Technology for Economic and Clinical Health Act (HITECH) Pub. L. 111-148, Patient Protection and Affordable Care Act (PPACA) Pub. L. 114-10, Medicare Access and CHIP Reauthorization Act (MACRA) Pub. L. 114-255,21st Century Cures Pub. L. 114-270, Expanding Capacity for Health Outcomes Act (ECHO) Pub. L. 114-328, National Defense Authorization Act for Fiscal Year 2017
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2016 · fourth_quarter · Medical/Disease Research/Clinical Labs
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2016 · fourth_quarter · Health Issues
Access to treatments for people with Sickle Cell Disease, treatment center model H.R. 1807: Sickle Cell Legislation Engaging NIH/CDC on hematology issues Research at NHLBI & NIDDK Cures
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2016 · third_quarter · Health Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions Section 340B Drug Pricing Program H.R. 6 (21st Century Cures Act), entire bill and Senate companion FDA reform legislation generally Stark Law reform generally H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments H.R. 1807 (Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015), entire bill Hospital Outpatient Prospective Payment System regulations regarding hospital outpatient department regulations Federal policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs Reauthorization of Children's Hospital Graduate Medical Education program
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · third_quarter · Health Issues
Implementation of Health care reform generally pertaining to pediatric healthcare and autism services Medicaid program reforms, including hospital outpatient department regulations H.R. 546 and S.298 (ACE Kids Act of 2015), all provisions Section 340B Drug Pricing program H.R. 6 (21st century cures Act), entire bill and senate companion FDA reform legislation generally Stark Law Reform generally H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments H.R. 1807 (Sickle Cell Disease research, Surveillance, Prevention, and treatment Act of 2015), entire bill Hospital Outpatient Prospective payment system regulations regarding hospital outpatient department regulations Federal Policy regarding United Network for Organ Sharing (UNOS) and allocation of donated organs Reauthorization of Children's Hospital Graduate Medical Education program S.2873 and H.R.5395 (Expanding Capacity for Health Outcomes Act), all provisions S.1878 and H.R.1537 (Advancing Hope Act), all provisions S.Res.592 (A resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month"), all provisions Centers for Medicare & Medicaid Services Patient Billing Issues
Client expense: $123,999 · Firm income: Not reported
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Sickle Cell Disease/Trait Issues Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
Client expense: $30,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
2016 · third_quarter · Health Issues
Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015 (H.R. 1807) Advancing Hope Act (H.R. 1537/S. 1878) Resolution expressing support for the designation of the month of September 2016 as "Sickle Cell Disease Awareness Month" (S.Res. 592/H.Res. 903) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Client expense: $30,000 · Firm income: Not reported
2016 · third_quarter · Medical/Disease Research/Clinical Labs
Research in hematology; legislation to enhance federal efforts on research training and services for sickle cell disease. HR 1807, Sickle Cell Disease Research Surveillance Prevention and Treatment Act of 2015; Resolution on Sickle Cell Disease Trait
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
2016 · third_quarter · Health Issues
Access to treatments for people with Sickle Cell Disease, treatment center model H.R. 1807: Sickle Cell Legislation Engaging NIH/CDC on hematology issues Research at NHLBI & NIDDK Cures
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
2016 · second_quarter · Health Issues
Implementation of health care reform generally pertaining to pediatric health care and autism services Medicaid program reforms, including hospital outpatient department regulations H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions Section 340B Drug Pricing Program H.R. 6 (21st Century Cures Act), entire bill and Senate companion FDA reform legislation generally Stark Law reform generally H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments H.R. 1807 (Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2015), entire bill S. 2614 (Kevin and Avonte's Law of 2016), entire bill H.R. 4725 (Common Sense Savings Act of 2016), Section 4, regarding provider taxes
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2016 · second_quarter · Health Issues
Implementation of health care reform generally pertaining to pediactric health care and autism services Medicaid program reforms, including hospital outpatient department regulations H.R. 546 and S. 298 (ACE Kids Act of 2015), all provisions Section 340B Drug Pricing Program H.R. 6 (21st Century Cures Act),entire bill and Senate companion FDA reform legislation generally H.R. 5273 (Helping Hospitals Improve Patient Care Act of 2016), Section 201, regarding hospital outpatient departments H.R. 1807 (Sickle Cell Disease Research, Surveillance, Prevention and Treatment Act of 2015), entire bill S. 2614 (Kevin and Avonte's Law of 2016), entire bill H.R. 4725 (Common Sense Savings Act of 2016), section 4, regarding provider taxes Pediatric oncology research and the Pediatric Research Equity Act of 2003 (PREA) Organ Procurement and Transplantation Network (OPTN), liver redistricting proposal S.2041/H.R.5182 (Promoting Life-Saving New Therapies for Neonates Act of 2015), all provisions
Client expense: $122,042 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| PA |
| Charles B. Rangel | Democratic | NY |
| David Scott | Democratic | GA |
| Frederica S. Wilson | Democratic | FL |
| John A. Yarmuth | Democratic | KY |
| John Conyers, Jr. | Democratic | MI |
| Michael C. Burgess | Republican | TX |
| Robert A. Brady | Democratic | PA |
| Sheila Jackson Lee | Democratic | TX |
| Todd Young | Republican | IN |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)